Opportunity Information: Apply for PA 18 907

This National Institutes of Health (NIH) grant opportunity, titled "New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed)" (Funding Opportunity Number: PA-18-907; CFDA: 93.242), supports research projects focused on building next-generation computational, bioinformatic, and statistical approaches that can clarify what genetic variants linked to mental disorders actually do biologically. The emphasis is on mental illnesses with complex causes, where many variants each contribute small effects and where brain-specific biology introduces extra layers of complexity compared to other organ systems. Rather than funding clinical trials, the FOA is designed to strengthen the computational toolkit needed to move from association signals found in genome-wide association studies (GWAS) or sequencing studies to credible functional interpretations that can guide biology-driven treatment discovery.

At its core, the program aims to close a persistent gap in psychiatric genetics: large studies can identify DNA variants associated with disorders, but translating those findings into mechanisms, affected cell types, pathways, and therapeutic hypotheses remains difficult. This FOA prioritizes method development that improves functional inference, such as approaches to pinpoint likely causal variants within associated loci, connect variants to regulatory elements and target genes, infer effects in specific brain regions or cell types, and integrate diverse data modalities. The opportunity explicitly recognizes that the brain presents special challenges, including high cellular diversity, developmental timing effects, context-specific gene regulation, and limited accessibility of living brain tissue. As a result, proposed methods are expected to account for nuances like cell-type specificity, spatiotemporal regulation across development, and the interpretation of noncoding variation that may influence gene regulation rather than protein sequence.

The mechanism is an R01 delivered as a collaborative (linked) set of applications, intended for projects that genuinely require two or more research sites to succeed. Each participating site submits its own linked R01 application and must name its own Program Director/Principal Investigator. The linked structure is meant to support coordinated multi-site science while maintaining clear responsibility and accountability at each institution. The collaborative format also highlights practical infrastructure needs that are often essential for computational method development at scale, including cross-site coordination plans, harmonized quality control procedures, shared database or data management strategies, statistical analysis coordination, and consistent reporting across the team. In other words, this is not just multiple groups working in parallel; it is a formally integrated effort with explicit plans for how the consortium will operate as a single coherent project.

The eligible applicant pool is broad and includes many types of U.S. governmental entities and organizations, such as state, county, city or township governments, special district governments, and independent school districts, as well as public and state-controlled institutions of higher education, private institutions of higher education, small businesses, and for-profit organizations (other than small businesses). It also includes a wide range of nonprofit organizations, both with and without 501(c)(3) status, and Native American tribal governments (federally recognized) and tribal organizations (including those other than federally recognized tribal governments). The FOA also explicitly names additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. (foreign) entities. This breadth signals NIH interest in drawing on diverse institutional strengths, including data science, neuroscience, psychiatry, genetics, and community-rooted research capacity, while still keeping the scope centered on computational and statistical innovation rather than interventional clinical research.

Administratively, this is a discretionary grant program run through NIH, created on August 29, 2018, with an original closing date listed as May 7, 2022. The opportunity listing does not specify an award ceiling or the expected number of awards in the provided text, which typically means applicants would need to consult the full FOA and NIH institute-specific guidance for budgeting expectations, project period norms, and any caps or constraints that could apply. The key operational takeaway is that the FOA is built for multi-institution collaborations developing methods that can translate psychiatric genetic findings into functional understanding, with the long-term vision of enabling new therapeutics grounded in human biology rather than relying only on symptom-based frameworks.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2018-08-29.
  • Applicants must submit their applications by 2022-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PA 18 907

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional)

Previous opportunity: Research Supplements to Promote Data Sharing in Cancer Epidemiology Studies (Admin Supp Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 18 907

 

Applicants also applied for:

Applicants who have applied for this opportunity (PA 18 907) also looked into and applied for these:

Funding Opportunity
Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trials Not Allowed) Apply for PAR 18 909

Funding Number: PAR 18 909
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required) Apply for PAR 18 910

Funding Number: PAR 18 910
Agency: National Institutes of Health
Category: Health
Funding Amount: $3,000,000
U.S. - India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed) Apply for PAR 18 912

Funding Number: PAR 18 912
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)- Clinical Trial Not Allowed Apply for PA 18 914

Funding Number: PA 18 914
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Implementation of PCOR Evidence (R18) Apply for RFA HS 18 002

Funding Number: RFA HS 18 002
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R01 Clinical Trial Optional) Apply for RFA MH 19 510

Funding Number: RFA MH 19 510
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) Apply for PAR 18 923

Funding Number: PAR 18 923
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimers Dementia (R21 Clinical Trial Optional) Apply for RFA MH 19 511

Funding Number: RFA MH 19 511
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp) Apply for PA 18 926

Funding Number: PA 18 926
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional) Apply for PA 18 928

Funding Number: PA 18 928
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional) Apply for PA 18 927

Funding Number: PA 18 927
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) Apply for RFA DE 19 005

Funding Number: RFA DE 19 005
Agency: National Institutes of Health
Category: Health
Funding Amount: $650,000
Research Centers in Minority Institutions (RCMI) (U54)- Clinical Trials Optional Apply for RFA MD 18 012

Funding Number: RFA MD 18 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) Apply for PAR 18 929

Funding Number: PAR 18 929
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed) Apply for PAR 18 930

Funding Number: PAR 18 930
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 Non-Construction (Admin Supp Clinical Trial Optional) Apply for PA 18 936

Funding Number: PA 18 936
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) Apply for PA 18 939

Funding Number: PA 18 939
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) Apply for PA 18 937

Funding Number: PA 18 937
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical and Translational Science Award (U54 Clinical Trial Optional) Apply for PAR 18 940

Funding Number: PAR 18 940
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional) Apply for PAR 18 941

Funding Number: PAR 18 941
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 907", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: